GOP Congressman Eager to Push Psychedelics Reform Under Trump Team

GOP Representative Dan Crenshaw is optimistic about the future of psychedelic research, citing a "friendlier" atmosphere within the current Trump administration. During a recent Fox News appearance, the Texas congressman highlighted his push to double federal funding for clinical trials involving substances like psilocybin and MDMA, particularly for active-duty military members. With high-ranking officials like RFK Jr. and VA Secretary Doug Collins showing openness to these "breakthrough therapies," the long-standing stigma around these plants and compounds is finally beginning to fade at the federal level.

This shift is a massive win for the community because it signals that the government is moving away from "Reefer Madness" era taboos and toward science-backed accessibility. For everyday enthusiasts and veterans alike, seeing bipartisan support for psychedelics suggests that we are closer than ever to a world where therapeutic options are defined by their efficacy rather than outdated politics. When the Department of Defense and the VA start leading the way on plant medicine, it paves a smoother path for broader legalization and safe, regulated access for everyone.